High-dose vascular endothelial growth factor increases surfactant protein gene expressions in preterm rat lung

Chung Ming Chen, Leng-Fang Wang

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Aims: To investigate the effects of intra-amniotic vascular endothelial growth factor (VEGF) treatment on surfactant pool sizes and surfactant protein (SP) gene expressions in fetal rat lung. Method: On the 18th day of gestation, an abdominal midline incision was performed on timed pregnant Sprague-Dawley rats and the two uterine horns were exposed. VEGF (2.5 μg or 5.0 μg) and saline were injected into the amniotic cavity of the left and right uterine horns, respectively. On the 19th day of gestation, fetuses were delivered by caesarean section. Results: We analyzed the data between the fetuses within the same dam in each group. Mean fetal body weight and lung tissue saturated phosphatidylcholine and total phospholipids were comparable between control and VEGF-treated rats at each VEGF dosage. Lung SP mRNA expressions were comparable between control and VEGF 2.5 μg-treated rats. VEGF 5.0 μg treatment increased lung SP mRNA expressions and the values were statistically significant for SP-B and SP-D mRNAs when compared with the control rats. Conclusions: These results suggest that VEGF might have potential therapeutic implications in enhancing fetal lung maturation.

Original languageEnglish
Pages (from-to)581-584
Number of pages4
JournalEarly Human Development
Volume83
Issue number9
DOIs
Publication statusPublished - Sep 2007

Fingerprint

Surface-Active Agents
Vascular Endothelial Growth Factor A
Gene Expression
Lung
Pulmonary Surfactant-Associated Proteins
Proteins
Messenger RNA
Fetus
Pulmonary Surfactant-Associated Protein D
Pregnancy
Fetal Weight
Phosphatidylcholines
Cesarean Section
Sprague Dawley Rats
Phospholipids

Keywords

  • Surfactant proteins;
  • Surfactant;
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

High-dose vascular endothelial growth factor increases surfactant protein gene expressions in preterm rat lung. / Chen, Chung Ming; Wang, Leng-Fang.

In: Early Human Development, Vol. 83, No. 9, 09.2007, p. 581-584.

Research output: Contribution to journalArticle

@article{cb0fd70091244d70bcc0753e84dcb0ec,
title = "High-dose vascular endothelial growth factor increases surfactant protein gene expressions in preterm rat lung",
abstract = "Aims: To investigate the effects of intra-amniotic vascular endothelial growth factor (VEGF) treatment on surfactant pool sizes and surfactant protein (SP) gene expressions in fetal rat lung. Method: On the 18th day of gestation, an abdominal midline incision was performed on timed pregnant Sprague-Dawley rats and the two uterine horns were exposed. VEGF (2.5 μg or 5.0 μg) and saline were injected into the amniotic cavity of the left and right uterine horns, respectively. On the 19th day of gestation, fetuses were delivered by caesarean section. Results: We analyzed the data between the fetuses within the same dam in each group. Mean fetal body weight and lung tissue saturated phosphatidylcholine and total phospholipids were comparable between control and VEGF-treated rats at each VEGF dosage. Lung SP mRNA expressions were comparable between control and VEGF 2.5 μg-treated rats. VEGF 5.0 μg treatment increased lung SP mRNA expressions and the values were statistically significant for SP-B and SP-D mRNAs when compared with the control rats. Conclusions: These results suggest that VEGF might have potential therapeutic implications in enhancing fetal lung maturation.",
keywords = "Surfactant proteins;, Surfactant;, Vascular endothelial growth factor",
author = "Chen, {Chung Ming} and Leng-Fang Wang",
year = "2007",
month = "9",
doi = "10.1016/j.earlhumdev.2006.12.005",
language = "English",
volume = "83",
pages = "581--584",
journal = "Early Human Development",
issn = "0378-3782",
publisher = "Elsevier Ireland Ltd",
number = "9",

}

TY - JOUR

T1 - High-dose vascular endothelial growth factor increases surfactant protein gene expressions in preterm rat lung

AU - Chen, Chung Ming

AU - Wang, Leng-Fang

PY - 2007/9

Y1 - 2007/9

N2 - Aims: To investigate the effects of intra-amniotic vascular endothelial growth factor (VEGF) treatment on surfactant pool sizes and surfactant protein (SP) gene expressions in fetal rat lung. Method: On the 18th day of gestation, an abdominal midline incision was performed on timed pregnant Sprague-Dawley rats and the two uterine horns were exposed. VEGF (2.5 μg or 5.0 μg) and saline were injected into the amniotic cavity of the left and right uterine horns, respectively. On the 19th day of gestation, fetuses were delivered by caesarean section. Results: We analyzed the data between the fetuses within the same dam in each group. Mean fetal body weight and lung tissue saturated phosphatidylcholine and total phospholipids were comparable between control and VEGF-treated rats at each VEGF dosage. Lung SP mRNA expressions were comparable between control and VEGF 2.5 μg-treated rats. VEGF 5.0 μg treatment increased lung SP mRNA expressions and the values were statistically significant for SP-B and SP-D mRNAs when compared with the control rats. Conclusions: These results suggest that VEGF might have potential therapeutic implications in enhancing fetal lung maturation.

AB - Aims: To investigate the effects of intra-amniotic vascular endothelial growth factor (VEGF) treatment on surfactant pool sizes and surfactant protein (SP) gene expressions in fetal rat lung. Method: On the 18th day of gestation, an abdominal midline incision was performed on timed pregnant Sprague-Dawley rats and the two uterine horns were exposed. VEGF (2.5 μg or 5.0 μg) and saline were injected into the amniotic cavity of the left and right uterine horns, respectively. On the 19th day of gestation, fetuses were delivered by caesarean section. Results: We analyzed the data between the fetuses within the same dam in each group. Mean fetal body weight and lung tissue saturated phosphatidylcholine and total phospholipids were comparable between control and VEGF-treated rats at each VEGF dosage. Lung SP mRNA expressions were comparable between control and VEGF 2.5 μg-treated rats. VEGF 5.0 μg treatment increased lung SP mRNA expressions and the values were statistically significant for SP-B and SP-D mRNAs when compared with the control rats. Conclusions: These results suggest that VEGF might have potential therapeutic implications in enhancing fetal lung maturation.

KW - Surfactant proteins;

KW - Surfactant;

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=34548490768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548490768&partnerID=8YFLogxK

U2 - 10.1016/j.earlhumdev.2006.12.005

DO - 10.1016/j.earlhumdev.2006.12.005

M3 - Article

C2 - 17267143

AN - SCOPUS:34548490768

VL - 83

SP - 581

EP - 584

JO - Early Human Development

JF - Early Human Development

SN - 0378-3782

IS - 9

ER -